Advancing CAT Care: New Insights on Extended Anticoagulation from Gerotziafas and Tafur
Grigoris Gerotziafas, Professor of Hematology at the Faculty of Medicine, Sorbonne University, Paris, and Head of the Thrombosis Department at Tenon Hospital in Paris, shared an insightful post on LinkedIn:
“We are pleased to share the publication, led by Prof. Alfonso Tafur (Department of Medicine, Vascular Medicine, Endeavor Health, Evanston, Illinois, University of Chicago, USA), of an important article on “Extended anticoagulation in patients with cancer-associated venous thromboembolism.”
This work highlights the challenges and strategies for managing CAT in oncology care and underscores the impact of the API-CAT study on optimizing antithrombotic treatment for patients with cancer-associated thrombosis.
The article emphasizes the urgent need to establish dedicated cancer thrombosis clinics to support shared decision-making and provide tailored management for patients.
We are proud to contribute to this significant initiative in collaboration with:
- CaVITE Thrombosis Center, Centre de Recherche Saint-Antoine (CRSA), INSERM U938, Sorbonne University, Paris, France, and
- Center for Translational Research and Education, Department of Pathology and Laboratory Medicine, Loyola University Stritch School of Medicine, Maywood, Chicago, USA.
Together, we aim to bridge science and clinical practice, delivering patient-centered strategies that enhance diagnosis, treatment, and prognosis for individuals facing cancer-associated thrombosis.”
Read the full article here:
Article: Extended anticoagulation in patients with cancer-associated venous thromboembolism
Authors: Atefeh Ghorbanzadeh, Mateo Porres-Aguilar, Robert McBane, Grigoris Gerotziafas, Alfonso Tafur
Discover the latest developments in coagulation and thrombosis research with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis